The Board has decided to remand the case due to a duty to assist error, requiring a VA examination to determine if amyloidosis is related to service.
The deciding factor: The decision was made based on an error in obtaining a VA examination prior to the October 2019 rating decision regarding whether amyloidosis had its onset in service or is otherwise related to service, to include as due to claimed munitions exposure.
- Claimed conditions
- amyloidosis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- November 18, 2021
- Citation
- A21018460
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation A21018460.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Board has decided that the Veteran's amyloidosis is due to exposure to herbicide agents, but there was a duty to assist error in not obtaining an opinion on whether his ATTR amyloidosis is a form of AL amyloidosis or if it is related to herbicide agent exposure. The case is being remanded for further development.
- Whole decision: Remanded (sent back)
The Board has remanded the claims for service connection due to a lack of documentation regarding toxic exposure risk activities (TERA) and an ILER. The Veteran is required to provide evidence that he was exposed to TERA during his active duty, which will then allow for a medical examination and opinion on whether his disabilities are related to service.
- Whole decision: Denied
The Veteran's claims for service connection for TTP, amyloidosis, and prostate cancer were denied as they are not supported by evidence showing a causal relationship to service prior to the PACT Act of August 10, 2022.
- Whole decision: Dismissed
The appeal for service connection for residuals of a Covid disability was dismissed due to the untimely filing of a notice of disagreement. The claim for amyloidosis is remanded for further development.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.